Kimberly Blackwell - 13 Nov 2023 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role: Chief Executive Officer, Director
Signature: By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kimberly Blackwell
Issuer symbol: ZNTL
Transactions as of: 13 Nov 2023
Net transactions value: +$51,448
Form type: 4
Filing time: 13 Nov 2023, 17:24:08 UTC
Previous filing: 29 Jun 2023
Next filing: 05 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZNTL	Common Stock	Purchase	$51,448	+5,000	+2%	$10.29	254,800	13 Nov 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.